Huadong Medicine Company Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Huadong Medicine Company Limited with three other
companies in this sector in China:
Zhejiang International Group Company Limited
sales of 17.26 billion Chinese Renmimbi [US$2.51 billion]
of which 100%
was Medicine Retailing),
Yunnan Baiyao Group Co., Ltd.
(22.41 billion Chinese Renmimbi [US$3.25 billion]
of which 59%
was Comodities Trading), and
China Medicine Health Industry Co Ltd
(25.74 billion Chinese Renmimbi [US$3.74 billion]
of which 67%
was Pharmaceutical Business).
Huadong Medicine Company Limited reported sales of 25.38 billion Chinese Renmimbi (US$3.69 billion)
December of 2016.
increase of 16.8%
versus 2015, when the company's sales were 21.73 billion Chinese Renmimbi.
Sales at Huadong Medicine Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 128%).
Sales of Manufacturing saw an increase
17.8% in 2016, from
4.97 billion Chinese Renmimbi to 5.85 billion Chinese Renmimbi.
Not all segments of Huadong Medicine Company Limited experienced an increase in sales in 2016:
sales of Other Operating fell 10.1% to 33.80 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).